|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.14 USD | -1.01% |
|
-2.84% | +13.72% |
| 24/07 | Rothschild & Co Redburn Adjusts Price Target on Biogen to $210 From $190, Maintains Neutral Rating | MT |
| 21/07 | BofA Securities Adjusts Biogen Price Target to $215 From $217 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 216.63 | 216.63 | 216.12 |
| Spread/Res. | -7.61% | -7.61% | -7.39% |
| Spread/Supp. | +4.27% | +16.13% | +18.61% |
| Support | 191.95 | 172.34 | 168.74 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
